Has anyone confirmed with management that they are speaking at the conference. I didn't see it on their site. It would seem logical that if their still going to speak they must have something to contribute. The trials have been done for weeks they have to have a pretty good idea if it's a winner. They're not going to present at a conference like this and say their product doesnt work. If their in rationality suggests positive results.
The top line results will be announced in a news release. i was mailed the Therapeutic Area Partnerships brochure about a month ago. ZLCS was not one of the stocks listed on the agenda so it may have been a late add. Makes sense to me either way results go. Talking about positive Z160 results at a partnering meeting with Astra Zenica, PFE, Roche, and Sanofi in attendance sounds like excellent timing. However it is also appropriate place to highlight your new replacement drug if Z160 fails.